Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,495.93
    -1,422.90 (-2.85%)
     
  • CMC Crypto 200

    1,302.78
    -55.23 (-4.07%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l`Autorité des Marchés Financiers (Regulation of the French stock market authority)

Sanofi
a French société anonyme with a registered share capital of 2,522,417,258 €
Registered office : 54, rue La Boétie - 75008 Paris - France
Registered at the Paris Commercial and Companies Registry under number 395 030 844

Date



Total number of
issued shares


Number of real
voting rights
(excluding treasury shares)

Theoretical number of
voting rights
(including treasury shares)*

October 31, 2017

1,263,134,158

1,399,188,617

1,409,742,698

* Pursuant to article 223-11 of the Règlement général de l`Autorité des Marchés Financiers.

ADVERTISEMENT

This information is also available on the internet website of sanofi under « Regulated Information in France »: http://en.sanofi.com/investors/regulated_info_france/regulated_info_france.asp

Investor Relations Department
Europe Tel: + 33 1 53 77 45 45 US Tel: + 1 908 981 5560
e-mail: IR@sanofi.com

Media Relations Department
Tel: + 33 1 53 77 46 46
e-mail: MR@sanofi.com

Press release (PDF)



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via GlobeNewswire

HUG#2149359